This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stiles, B. G.
Right arrow Articles by Boles, J. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stiles, B. G.
Right arrow Articles by Boles, J. W.

 Previous Article  |  Next Article 

Infection and Immunity, April 2001, p. 2031-2036, Vol. 69, No. 4
0019-9567/01/$04.00+0   DOI: 10.1128/IAI.69.4.2031-2036.2001

Mucosal Vaccination with Recombinantly Attenuated Staphylococcal Enterotoxin B and Protection in a Murine Model

Bradley G. Stiles,* Anthony R. Garza, Robert G. Ulrich, and James W. Boles

Toxinology and Aerobiology Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Maryland 21702-5011

Received 25 September 2000/Returned for modification 14 December 2000/Accepted 3 January 2001

Previous work in our laboratory revealed that mice parenterally vaccinated with recombinantly attenuated staphylococcal enterotoxin (SE) or toxic shock syndrome toxin 1 develop protective antibodies against a lethal intraperitoneal (i.p.) toxin challenge. This study investigated the efficacy of nasal and oral immunizations with an SEB vaccine (SEBv) toward an i.p. or mucosal (via an aerosol) toxin challenge. Both vaccination routes, with the immunoadjuvant cholera toxin (CT), elicited comparable SEB-specific immunoglobulin A (IgA) and IgG levels in saliva. Nasal or oral inoculations also generated SEB-specific IgA, IgG, and IgM in the serum, but the nasal route yielded higher specific IgG titers. SEBv alone, when given nasally or orally, did not induce any detectable SEB-specific antibody. Mice vaccinated mucosally were protected against a 50% lethal dose of wild-type SEB given i.p. or mucosally, thus demonstrating that nasal or oral administration of this SEBv, with CT, elicits systemic and mucosal antibodies to SEB that protect against SEB-induced lethal shock.


* Corresponding author. Mailing address: Toxinology and Aerobiology Division, Department of Immunology and Molecular Biology, USAMRIID, Fort Detrick, MD 21702-5011. Phone: (301) 619-4809. Fax: (301) 619-2348. E-mail: bradley.stiles{at}amedd.army.mil.


Infection and Immunity, April 2001, p. 2031-2036, Vol. 69, No. 4
0019-9567/01/$04.00+0   DOI: 10.1128/IAI.69.4.2031-2036.2001



This article has been cited by other articles:

  • Tollersrud, T., Kampen, A. H., Kenny, K. (2006). Staphylococcus aureus Enterotoxin D Is Secreted in Milk and Stimulates Specific Antibody Responses in Cows in the Course of Experimental Intramammary Infection.. Infect. Immun. 74: 3507-3512 [Abstract] [Full Text]  
  • O'Brien-Simpson, N. M., Pathirana, R. D., Paolini, R. A., Chen, Y.-Y., Veith, P. D., Tam, V., Ally, N., Pike, R. N., Reynolds, E. C. (2005). An Immune Response Directed to Proteinase and Adhesin Functional Epitopes Protects against Porphyromonas gingivalis-Induced Periodontal Bone Loss. J. Immunol. 175: 3980-3989 [Abstract] [Full Text]  
  • Hu, D.-L., Cui, J.-C., Omoe, K., Sashinami, H., Yokomizo, Y., Shinagawa, K., Nakane, A. (2005). A Mutant of Staphylococcal Enterotoxin C Devoid of Bacterial Superantigenic Activity Elicits a Th2 Immune Response for Protection against Staphylococcus aureus Infection. Infect. Immun. 73: 174-180 [Abstract] [Full Text]  
  • Etz, H., Minh, D. B., Henics, T., Dryla, A., Winkler, B., Triska, C., Boyd, A. P., Sollner, J., Schmidt, W., von Ahsen, U., Buschle, M., Gill, S. R., Kolonay, J., Khalak, H., Fraser, C. M., von Gabain, A., Nagy, E., Meinke, A. (2002). Identification of in vivo expressed vaccine candidate antigens from Staphylococcus aureus. Proc. Natl. Acad. Sci. USA 99: 6573-6578 [Abstract] [Full Text]  
  • Rajapakse, P. S., O'Brien-Simpson, N. M., Slakeski, N., Hoffmann, B., Reynolds, E. C. (2002). Immunization with the RgpA-Kgp Proteinase-Adhesin Complexes of Porphyromonas gingivalis Protects against Periodontal Bone Loss in the Rat Periodontitis Model. Infect. Immun. 70: 2480-2486 [Abstract] [Full Text]  
  • Shupp, J. W., Jett, M., Pontzer, C. H. (2002). Identification of a Transcytosis Epitope on Staphylococcal Enterotoxins. Infect. Immun. 70: 2178-2186 [Abstract] [Full Text]